The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 14, 2023
Filed:
Aug. 27, 2021
Applicant:
Alterity Therapeutics Limited, Melbourne, AU;
Inventors:
Silas Bond, Melbourne, AU;
Penelope Jane Huggins, Melbourne, AU;
Jack Gordon Parsons, Melbourne, AU;
Assignee:
Alterity Therapeutics Limited, Melbourne, AU;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/12 (2006.01); C07D 491/052 (2006.01); C07D 417/12 (2006.01); C07D 409/12 (2006.01); C07D 495/04 (2006.01); C07D 413/12 (2006.01); C07D 405/12 (2006.01); C07D 221/04 (2006.01); C07D 239/26 (2006.01); C07D 241/12 (2006.01); C07D 213/53 (2006.01); C07D 215/12 (2006.01); C07D 277/28 (2006.01); C07D 333/22 (2006.01); C07D 277/64 (2006.01); C07D 233/64 (2006.01); C07D 471/04 (2006.01); C07D 401/06 (2006.01); C07D 413/14 (2006.01); C07D 409/14 (2006.01); C07D 417/14 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01); C07D 215/40 (2006.01);
U.S. Cl.
CPC ...
C07D 401/12 (2013.01); C07D 213/53 (2013.01); C07D 215/12 (2013.01); C07D 215/40 (2013.01); C07D 221/04 (2013.01); C07D 233/64 (2013.01); C07D 239/26 (2013.01); C07D 241/12 (2013.01); C07D 277/28 (2013.01); C07D 277/64 (2013.01); C07D 333/22 (2013.01); C07D 401/06 (2013.01); C07D 401/14 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 409/12 (2013.01); C07D 409/14 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 417/12 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 491/052 (2013.01); C07D 495/04 (2013.01);
Abstract
The present invention relates to compounds that have zinc and/or iron ionophore activity and their use in treating diseases that are modulated by reducing zinc and/or iron. In particular embodiments, the compounds are compounds of formula (I):